WHO ICTRP trial
Evaluation of the safety and efficacy of Doxycycline in Chronic Meibomian Gland…
CTRI/2025/08/093711 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/08/093711 |
|---|---|
| Public title | Evaluation of the safety and efficacy of Doxycycline in Chronic Meibomian Gland Dysfunction |
| Scientific title | Efficacy and Safety of Oral Doxycycline in Chronic Meibomian Gland Dysfunction: A Randomized Control Trial (The ODCMD trial) - The ODCMD trial |
| Primary sponsor | Dr Phulen Sarma |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: H028- Other specified disorders of eyelid |
| Interventions | Intervention1: Doxycycline 20 mg + Standard of care (Lid scrub, lid message) + Tear substitute (CMC 4 times daily) + low-dose Doxycycline (20 mg twice daily) for 2 months.: Doxycycline 20 mg + Standard of care (Lid scrub, lid message) +… |
| Registration date | Aug 26, 2025 |
| Target size | 344 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: